Science Market Update

Bio Research Win: Supreme Court Rules Against Gene Patenting

Posted by Jaimee Saliba on Fri, Jun 14, 2013

In what is being hailed as a victory for both scientific research and patients' rights, the Supreme Court ruled unanimously yesterday that human genetic material cannot be patented. The case, Association for Molecular Pathology v. Myriad Genetics, has been working its way through the court system for a number of years now, led by plaintiffs including the ACLU, the American College of Medical Genetics, the American Society for Clinical Pathology, and numerous prominent genetic research scientists. The verdict invalidates the patents Myriad Genetics has held on breast cancer genes BRCA1 and BRCA2 since the 1990's and allows other labs besides theirs to test for mutations in those genes which, when present, strongly indicate a genetic predisposition to cancer. It also means that scientists can move forward in their genetic research without threat of being sued for copyright infringement. While the case was brought against Myriad specifically, the decision to disallow human gene patenting has profound implications for both scientific discovery and individual rights of ownership over our own genetic material.

Read More

Tags: 2014, CA, 2013, Bioresearch, gene patenting, cancer research, Southwest, Southwest life science marketing events, Cancer Treatment, San Diego, SDVS, Genetics, UC San Diego, biotech industry, Biotechnology Vendor Showcase

Georgetown Cancer Research Links High Estrogen Levels in Womb to BRCA1 Silencing

Posted by Jaimee Saliba on Fri, Apr 19, 2013

At Georgetown University's Lombardi Comprehensive Cancer Center, researchers have announced the results of an important study showing that high levels of estrogen in the mother during pregnancy can increase a daughter's susceptibility to breast cancer later on. Specifically, the BRCA1 gene is disabled in an estrogen-rich environment, preventing it from carrying out its DNA repair tasks and leaving an opening for cancerous cells to grow. The research was presented at the 2013 American Association for Cancer Research (AACR) meeting by Dr. Leena Hilakivi-Clarke (right). The Hilakivi-Clarke Lab is on the same floor of the Research Building as that of Dr. Robert Clarke, who collaborated on the study; the Clarkes both carry out hormone-related cancer research, and Robert Clarke is the Dean for Research at the Georgetown University Medical Center (GUMC). 

Read More

Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, gene patenting, cancer research, D.C., Geotwn, BioResearch Product Faire Event, Genetics, Georgetown University Medical Center

Will Life Science Research Benefit from Court Rulings against Human Gene Patents?

Posted by Jaimee Saliba on Mon, Apr 02, 2012

Last year in a blog of ours on the future of genome sequencing we referenced a July appeals court ruling that protected Utah's Myriad Genetics' patent on two genes known to be indicators of breast cancer risk.  Now, in a recent Supreme Court ruling on that same case, the previous ruling has been overturned and the case returned to the lower court for rehearing.  This decision follows another important high court ruling on the patentability of genes: Mayo vs. Prometheus Labs (San Diego), which also just ruled against a company's right to hold patents on human genes, and which was quoted as a precedent in the latest Myriad judgement.

Read More

Tags: Utah, gene patenting, DNA Sequencing, genome research, genomic medicine, Southwest, Life science branding, Genomics, Life Science Research Market, Univ of Utah

Genome Sequencing Research Moving at Warp Speed -- What to Expect

Posted by Jaimee Saliba on Fri, Sep 16, 2011

Read More

Tags: Northeast, Utah, gene patenting, genome research, Southwest, Massachusetts, Genomics, Lecture

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!